Vutrisiran in Transthyretin Amyloidosis: A Narrative Review

Kamela Lybeshari, Huy Pham, Genevieve Hale

Open source

DOI
10.1007/s40256-026-00824-6
Published
2026-08-20
Container
American Journal of Cardiovascular Drugs
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40256-026-00824-6,
  title = {Vutrisiran in Transthyretin Amyloidosis: A Narrative Review},
  author = {Kamela Lybeshari and Huy Pham and Genevieve Hale},
  year = {2026},
  journal = {American Journal of Cardiovascular Drugs},
  doi = {10.1007/s40256-026-00824-6},
  url = {https://doi.org/10.1007/s40256-026-00824-6}
}

RIS

TY  - JOUR
TI  - Vutrisiran in Transthyretin Amyloidosis: A Narrative Review
AU  - Kamela Lybeshari
AU  - Huy Pham
AU  - Genevieve Hale
PY  - 2026
JO  - American Journal of Cardiovascular Drugs
DO  - 10.1007/s40256-026-00824-6
UR  - https://doi.org/10.1007/s40256-026-00824-6
ER  - 

APA

Lybeshari, K., Pham, H., & Hale, G. (2026). Vutrisiran in Transthyretin Amyloidosis: A Narrative Review. American Journal of Cardiovascular Drugs. https://doi.org/10.1007/s40256-026-00824-6

Source records